Francis Perry Wilson1, Wei Yang, Harold I Feldman. 1. Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. francis.wilson@uphs.upenn.edu
Abstract
BACKGROUND AND OBJECTIVES: AKI carries a substantial risk of mortality, even after adjustment for comorbidities. Effective risk stratification may lead to more effective therapeutic interventions for high-risk subgroups. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study identified adults who suffered severe in-hospital AKI from January 1, 2004 to August 31, 2010 at three hospitals in the University of Pennsylvania Health System (UPHS). Patients were included if baseline creatinine was ≤1.4 mg/dl for men or ≤1.2 mg/dl for women, and serum creatinine doubled during the hospital admission. Cox proportional hazards models predicting death, dialysis, or a combined endpoint of death or dialysis were fit using data from patients admitted to the Hospital of the University of Pennsylvania (n=4263), and validated at the two other UPHS facilities (n=758, n=1098). RESULTS: In adjusted analyses, strong predictors of the combined endpoint included intensive care unit location (versus floor), medical service, liver disease, higher creatinine, greater rate of change in creatinine, and greater number of pressor medications. Higher absolute creatinine concentration was associated with greater use of dialysis, but lower overall mortality in adjusted analyses. Harrell's c-index (95% confidence interval) for the model predicting the combined endpoint was 0.85 (0.84-0.86) in the derivation cohort, and 0.83 (0.80-0.86) and 0.84 (0.82-0.86) in the validation cohorts. CONCLUSIONS: A small group of easily measured clinical factors has good ability to predict mortality and dialysis in severe AKI.
BACKGROUND AND OBJECTIVES: AKI carries a substantial risk of mortality, even after adjustment for comorbidities. Effective risk stratification may lead to more effective therapeutic interventions for high-risk subgroups. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This study identified adults who suffered severe in-hospital AKI from January 1, 2004 to August 31, 2010 at three hospitals in the University of Pennsylvania Health System (UPHS). Patients were included if baseline creatinine was ≤1.4 mg/dl for men or ≤1.2 mg/dl for women, and serum creatinine doubled during the hospital admission. Cox proportional hazards models predicting death, dialysis, or a combined endpoint of death or dialysis were fit using data from patients admitted to the Hospital of the University of Pennsylvania (n=4263), and validated at the two other UPHS facilities (n=758, n=1098). RESULTS: In adjusted analyses, strong predictors of the combined endpoint included intensive care unit location (versus floor), medical service, liver disease, higher creatinine, greater rate of change in creatinine, and greater number of pressor medications. Higher absolute creatinine concentration was associated with greater use of dialysis, but lower overall mortality in adjusted analyses. Harrell's c-index (95% confidence interval) for the model predicting the combined endpoint was 0.85 (0.84-0.86) in the derivation cohort, and 0.83 (0.80-0.86) and 0.84 (0.82-0.86) in the validation cohorts. CONCLUSIONS: A small group of easily measured clinical factors has good ability to predict mortality and dialysis in severe AKI.
Authors: C E Douma; W K Redekop; J H van der Meulen; R W van Olden; J Haeck; D G Struijk; R T Krediet Journal: J Am Soc Nephrol Date: 1997-01 Impact factor: 10.121
Authors: Hude Quan; Vijaya Sundararajan; Patricia Halfon; Andrew Fong; Bernard Burnand; Jean-Christophe Luthi; L Duncan Saunders; Cynthia A Beck; Thomas E Feasby; William A Ghali Journal: Med Care Date: 2005-11 Impact factor: 2.983
Authors: J C Fink; R A Burdick; S J Kurth; S A Blahut; N C Armistead; M S Turner; L M Shickle; P D Light Journal: Am J Kidney Dis Date: 1999-10 Impact factor: 8.860
Authors: Ravindra L Mehta; Maria T Pascual; Sharon Soroko; Brandon R Savage; Jonathan Himmelfarb; T Alp Ikizler; Emil P Paganini; Glenn M Chertow Journal: Kidney Int Date: 2004-10 Impact factor: 10.612
Authors: F Perry Wilson; Michael Shashaty; Jeffrey Testani; Iram Aqeel; Yuliya Borovskiy; Susan S Ellenberg; Harold I Feldman; Hilda Fernandez; Yevgeniy Gitelman; Jennie Lin; Dan Negoianu; Chirag R Parikh; Peter P Reese; Richard Urbani; Barry Fuchs Journal: Lancet Date: 2015-02-26 Impact factor: 79.321
Authors: F Perry Wilson; Wei Yang; Carlos A Machado; Laura H Mariani; Yuliya Borovskiy; Jeffrey S Berns; Harold I Feldman Journal: Clin J Am Soc Nephrol Date: 2014-03-20 Impact factor: 8.237
Authors: Francis Perry Wilson; Peter P Reese; Michael Gs Shashaty; Susan S Ellenberg; Yevgeniy Gitelman; Amar D Bansal; Richard Urbani; Harold I Feldman; Barry Fuchs Journal: Clin Trials Date: 2014-07-14 Impact factor: 2.486
Authors: Michael Heung; Diane E Steffick; Kara Zivin; Brenda W Gillespie; Tanushree Banerjee; Chi-Yuan Hsu; Neil R Powe; Meda E Pavkov; Desmond E Williams; Rajiv Saran; Vahakn B Shahinian Journal: Am J Kidney Dis Date: 2015-12-12 Impact factor: 8.860
Authors: Adam Lewis; Lisa Bastarache; Anita Pandit; Daniel B Larach; Jing He; Anik Sinha; Nicholas J Douville; Michael Heung; Michael R Mathis; Jonathan D Mosley; Jonathan P Wanderer; Sachin Kheterpal; Matthew Zawistowski; Chad M Brummett; Edward D Siew; Cassianne Robinson-Cohen; Miklos D Kertai Journal: BMC Nephrol Date: 2022-10-21 Impact factor: 2.585
Authors: Michael Heung; Sarah Faubel; Suzanne Watnick; Dinna N Cruz; Jay L Koyner; Girish Mour; Kathleen D Liu; Jorge Cerda; Mark D Okusa; Mark Lukaszewski; Anitha Vijayan Journal: Clin J Am Soc Nephrol Date: 2015-07-28 Impact factor: 8.237
Authors: F Perry Wilson; Wei Yang; Sarah Schrauben; Carlos Machado; Jennie J Lin; Harold I Feldman Journal: Clin J Am Soc Nephrol Date: 2013-08-22 Impact factor: 8.237
Authors: Sidney Le; Angier Allen; Jacob Calvert; Paul M Palevsky; Gregory Braden; Sharad Patel; Emily Pellegrini; Abigail Green-Saxena; Jana Hoffman; Ritankar Das Journal: Kidney Int Rep Date: 2021-02-26
Authors: Francis Perry Wilson; Amar D Bansal; Sravan K Jasti; Jennie J Lin; Michael G S Shashaty; Jeffrey S Berns; Harold I Feldman; Barry D Fuchs Journal: Clin Nephrol Date: 2013-12 Impact factor: 0.975